论文期刊

取消

高级检索

检索历史清除

首页> Expert opinion on drug safety> The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.

The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.

导出 LinkOut

翻译打印收藏纠错

作者： Qingnan,Zhao ^[1] ; Yijiong,Tan ^[2] ; Qinqin,Wu ^[1] ; Xiangqin,Xiao ^[3] ; Xinyi,Wei ^[1] ; Mengqing,Nian ^[4] ; Jie,Yao ^[5] ; Nengguang,Fan ^[5] ; Ruiping,Wang ^[6] ; Guorong,Fan ^[7]

作者单位： Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[1] Shanghai Key Laboratory of Pancreatic Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[2] Department of Pharmacy, Community Health Service Center of Guangfulin Street, Shanghai, China. ^[3] School of Public Health, Nanjing Medical University, Nanjing, China. ^[4] School of pharmacy, Nanjing Medical University, Nanjing, China. ^[5] Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[6] Clinical Research Center, Shanghai Skin Diseases Hospital, Tongji Medical University, Shanghai, China. ^[7]

关键词 Type 2 diabetes mellitus dapagliflozin diabetic ketoacidosis diabetic ketosis risk factor

主题词人类(Humans);中年人(Middle Aged);糖尿病酮症酸中毒(Diabetic Ketoacidosis);糖尿病, 2型(Diabetes Mellitus, Type 2);回顾性研究(Retrospective Studies);阿卡波糖(Acarbose);中国(China);危险因素(Risk Factors);胰岛素(Insulin);二苯甲基化合物(Benzhydryl Compounds);葡糖苷类(Glucosides)

DOI 10.1080/14740338.2023.2275704

PMID 37947121

发布时间 2024-02-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Expert opinion on drug safety

Expert opinion on drug safety

2024年23卷1期

57-65页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷